Mohamed Zaki - Jan 2, 2024 Form 3 Insider Report for ADC Therapeutics SA (ADCT)

Role
Chief Medical Officer
Signature
/s/ Ameet Mallik, as Attorney-in-Fact for Mohamed Zaki
Stock symbol
ADCT
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
3
Date filed
1/2/2024, 08:05 PM
Next filing
Dec 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADCT Common Shares 270K Jan 2, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADCT Stock Options (Right to Buy) Jan 2, 2024 Common Shares 700K $3.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Shares to be delivered in settlement of a restricted share unit award which vests 50% on the one-year anniversary of the grant date, which grant date is December 6, 2023 and on the two-year anniversary of the grant date, upon continued service through the designated vesting event.
F2 This option vests over four years from January 3, 2023, with 1/4 vesting on the first anniversary of such date, and the remainder vesting monthly in 36 equal installments, subject to continued service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney